Literature DB >> 23131837

Synthesis, structure, magnetic properties and theoretical calculations of methoxy bridged dinuclear iron(III) complex with hydrazone based O,N,N-donor ligand.

Rahman Bikas1, Hassan Hosseini-Monfared, Giorgio Zoppellaro, Radovan Herchel, Jiri Tucek, Anita M Owczarzak, Maciej Kubicki, Radek Zboril.   

Abstract

Biomimetic complexes are artificially engineered molecules that aim to reduce the structural complexity of biological systems in order to unveil the key electronic and structural factors relevant to a protein's function. In this work, a novel coordination compound (L2Fe2) which mimics non-heme binuclear proteins was synthesized from the Schiff-base ligand HL = (E)-N′-(phenyl(pyridin-2-yl)methylene)isonicotinohydrazide. The crystal structure of L2Fe2 showed that the intramolecular FeFe distances (3.1–3.2 Å) were analogous to those found in non-heme binuclear ferric proteins. However, in L2Fe2, two methoxide groups act as bridging units for oxidized iron (Fe3+). Such a bridging motif is unprecedented in the biological realm. Magnetic susceptibility measurements demonstrated that L2Fe2 is characterized by a singlet (S = 0) ground state and a very small magnetic coupling constant J (≪ −1 cm(−1)). The J value featured by L2Fe2 differs considerably from the values observed in non-heme binuclear proteins in the oxidized form (−100 cm(−1) < J < −10 cm(−1)), which encompass oxo/hydroxo and carboxylate bridging residues. The singlet ground state of L2Fe2 as well as the weak magnetic interaction between the two ferric cations was successfully predicted by density functional theory (DFT).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23131837     DOI: 10.1039/c2dt31751f

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  1 in total

1.  Green solvent free epoxidation of olefins by a heterogenised hydrazone-dioxidotungsten(vi) coordination compound.

Authors:  Neda Heydari; Rahman Bikas; Maryam Shaterian; Tadeusz Lis
Journal:  RSC Adv       Date:  2022-02-09       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.